https://scholars.lib.ntu.edu.tw/handle/123456789/496586
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | Kuo C.-H. | en_US |
dc.contributor.author | SHYANG-RONG SHIH | en_US |
dc.contributor.author | HUNG-YUAN LI | en_US |
dc.contributor.author | Chen S.-C. | en_US |
dc.contributor.author | Hung P.-J. | en_US |
dc.contributor.author | FEN-YU TSENG | en_US |
dc.contributor.author | TIEN-CHUN CHANG | en_US |
dc.creator | TIEN-CHUN CHANG;Tseng F.-Y.;Hung P.-J.;Chen S.-C.;Li H.-Y.;Shih S.-R.;Kuo C.-H. | - |
dc.date.accessioned | 2020-06-03T07:23:39Z | - |
dc.date.available | 2020-06-03T07:23:39Z | - |
dc.date.issued | 2017 | - |
dc.identifier.issn | 0929-6646 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85006007505&doi=10.1016%2fj.jfma.2016.08.008&partnerID=40&md5=436af73972bb7bc54fcf3c6f0a886255 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/496586 | - |
dc.description.abstract | Background/Purpose Cushing's disease (CD) is the most common cause of endogenous Cushing's syndrome. Transsphenoidal surgery (TSS) is the first choice of treatment. Predicting prognosis after treatment can benefit further strategies of management, but currently there is no convenient predictor. This study aims to investigate characteristic changes after treatment and to identify potential prognostic predictors. Methods We retrospectively studied the records of CD patients presenting to the National Taiwan University Hospital, Taipei, Taiwan between 1992 and 2011. They were categorized according to treatment response. Clinical features and examination findings were compared between groups. Results Forty-one patients with CD were included. The follow-up time was 0.26–19.3?years. The time interval between the onset of symptoms and diagnosis was 2.1–120.0?months. The initial remission rate of CD after the first treatment was 82.9%. Mean body mass index (BMI) was 27.4?kg/m2 before treatment and 26.0?kg/m2 3?months after treatment. The patients in remission had a greater decrease in BMI after treatment and lower dehydroepiandrosterone sulfate (DHEAS) levels before treatment, compared with the recurrent group (both p?<?0.05). Adrenocorticotropic hormone (ACTH) levels before treatment showed a significant positive correlation with recurrent diseases (p?<?0.05). Conclusion A larger decrease in BMI after treatment and lower DHEAS levels before treatment were noted for the patients who stayed in CD remission. Higher ACTH levels before treatment predicted a recurrence of CD. These are potentially simple and practical predictors of prognosis. ? 2016 | - |
dc.publisher | Elsevier B.V. | - |
dc.relation.ispartof | Journal of the Formosan Medical Association | - |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | corticotropin; glucocorticoid; prasterone; corticotropin; prasterone sulfate; adult; Article; body mass; clinical article; clinical feature; controlled study; corticotropin blood level; Cushing disease; Cushing syndrome; diabetes insipidus; female; follow up; human; hypopituitarism; male; medical record review; prognosis; recurrent disease; remission; retrospective study; Taiwan; treatment response; adolescent; aged; blood; child; Cushing disease; middle aged; preschool child; recurrent disease; young adult; Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Body Mass Index; Child; Child, Preschool; Dehydroepiandrosterone Sulfate; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pituitary ACTH Hypersecretion; Recurrence; Retrospective Studies; Young Adult | - |
dc.title | Adrenocorticotropic hormone levels before treatment predict recurrence of Cushing's disease | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1016/j.jfma.2016.08.008 | - |
dc.identifier.pmid | 28029519 | - |
dc.identifier.scopus | 2-s2.0-85006007505 | - |
dc.relation.pages | 441-447 | - |
dc.relation.journalvolume | 116 | - |
dc.relation.journalissue | 6 | - |
item.fulltext | no fulltext | - |
item.openairetype | journal article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Medicine-NTUCC | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUHHC | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.orcid | 0000-0001-7424-1358 | - |
crisitem.author.orcid | 0000-0001-9644-2855 | - |
crisitem.author.orcid | 0000-0003-1571-5255 | - |
crisitem.author.orcid | 0000-0003-3385-2026 | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | National Taiwan University Cancer Center (NTUCC) | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | NTU Hsin-Chu Hospital | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。